4 Amendments of Monika BEŇOVÁ related to 2021/2132(DEC)
Amendment 2 #
Draft opinion
Paragraph 1
Paragraph 1
1. Emphasises the important role of the European Medicines Agency (‘the EMA') in protecting and promoting public human and animal health by making independent, science-based recommendations on the quality, safety and efficacy of medicines, and providing scientific advice and incentives to stimulate the development and improve the availability of innovative new medicines;
Amendment 6 #
Draft opinion
Paragraph 6
Paragraph 6
6. WelcomNotes the EMA’s decision to waive all fees for scientific advice applications from developers of potential COVID-19 therapeutics or vaccines as of 13 March 2020, and to waivewelcomes the waiving of all fees for provision of scientific advice to academic researchers developing orphan medicines from 19 June 2020; highlights that other instances of waiving fees subject to specific criteria set out by the EMA notably regarding SMEs should follow;
Amendment 7 #
Draft opinion
Paragraph 8
Paragraph 8
8. Is pleased that the EMA successfully maintained the quality and continuity of its operations whilst relocating its seat to its final premises in Amsterdam following the United Kingdom’s withdrawal from the Union; notes that potential liabilities arising from the lease on the EMA’s former office premises in London remain a matter of concern; recognises that the EMA was able to respond effectively to the workload associated with the COVID-19 pandemic and welcomes the work on facilitating access to new vaccines and therapeutics to treat and prevent the spread of COVID- 19;
Amendment 13 #
Draft opinion
Paragraph 14
Paragraph 14
14. Notes, in addition, that the Court identified public procurement weaknesses and also irregularities in a catering and restaurant services framework contract, including a failure to verify that the amounts invoiced were correct;